Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Gynecologic 13Tumor-Agnostic 12Gastrointestinal 11Thoracic 8Genitourinary 8Other hematologic neoplasm 6Breast 6NET 5Lymphoid 5Endocrine 5Dermatologic 5Head & Neck 4Plasma cell 3Other solid neoplasm 3CNS 3Sarcoma 2Myeloid 2Classical hematology 2

Conditions

Mesothelioma, Malignant 2Solid Tumor, Adult 1Mesothelioma 1

Interventions

Cisplatin 147pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 99Paclitaxel 97Gemcitabine 85Irinotecan 75Cyclophosphamide 72Nivolumab 71Docetaxel 68Bevacizumab 59Oxaliplatin 50Fluorouracil 50Capecitabine 48atezolizumab 46Leucovorin 42Etoposide 42tislelizumab 40toripalimab 36fludarabine 32Drug Therapy 32Ipilimumab 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Specimen Handling 26Radiotherapy 26Interviews as Topic 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Data Collection × Other solid neoplasm × Clear all
NCT05308966 2025-10-06

MESO-IMMUNE

Groupe Francais De Pneumo-Cancerologie

Completed
204 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT04775446 2022-02-04

MESOIMMUNE

Centre Hospitalier Intercommunal Creteil

Completed
116 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03927599 2019-08-20

Advanced Refractory Solid Tumors With TP53 Mutations Register Study

Tianjin Medical University Second Hospital

Unknown
100 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡